Experimental and clinical studies of cytokine gene-modified tumor cells.
about
Breast cancer vaccines: a clinical reality or fairy tale?Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.Tumor Therapy Applying Membrane-bound Form of Cytokines.Cancer vaccines: the interleukin 2 dosage effectA phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.Vaccines in oncology: background and clinical potential.Progress and limitations in cancer gene therapy.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?GM-CSF-secreting melanoma vaccines.Parvovirus vectors for cancer gene therapy.Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cellsGene therapy of benign gynecological diseases.Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.Transcriptional targeting of herpes simplex virus for cell-specific replication.Transloading of tumor antigen-derived peptides into antigen-presenting cellsMurine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivoTherapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.Systemic T cell-independent tumor immunity after transplantation of universal receptor-modified bone marrow into SCID mice.Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response.Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumorsThe Janus face of dendritic cells in cancer.Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth.Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours.The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.Can immunotherapy by gene transfer tip the balance against colorectal cancer?Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity.The potential applications of gene transfer in the treatment of patients with cancer: a concise review.Tumor immunotherapy by vaccination with cytokine gene transfected cells.Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype.IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response.Immunotherapy of Human Melanoma With Gene-Modified Tumor Cell Vaccines.Anti‐tumor immunity induced by tumor cells express a membrane‐bound form of IL‐2 and SDF‐1
P2860
Q30351838-41D862BF-F4FE-46AB-9143-CF7C3B5F59CDQ33178788-DC8A9B02-8B35-41EE-976E-4413693322B0Q33631960-50133025-38D9-41B0-BF37-1517A602A75FQ34361454-24292867-DC92-42B9-A859-4C23F20ED537Q34416464-F1B36E10-A674-4979-9C76-FA840495F983Q34439914-DAC049D5-5255-44EF-BBDE-7E1FE279D819Q35051969-1EC01DF7-542E-4D81-A89A-068DF3B2F1CAQ35142329-460D882B-9664-4234-BF67-2F095D851A5BQ35146599-2B3F7991-4F29-43C3-8C50-9DDA39A30228Q35609780-9C0DEFA1-3FA6-481F-9DEB-59AF2F8934A8Q35764615-28C4673A-26D1-4A3B-BFAA-29BE4B1339FCQ35770271-3306658E-5324-4D98-B408-4A8909777A49Q35796105-7D41B7D4-8DA0-4F24-87E7-4D0ACA9C3815Q35887944-F6D56457-918F-41AA-AE77-0B1ED339F837Q36084026-3E935DD0-E489-4314-8386-405F1FBB3AB8Q36262520-E6BCFDD9-06D0-44F6-954D-60FB40EDCFFEQ36366108-6244106A-92E3-4F1D-9402-D93235BA74BDQ36377445-3ED1A7C9-526C-4774-9E42-ED3ED0A051BDQ36394033-19ACBC96-CD52-4DD4-866D-55C927FBCE0DQ36801817-ACAA4736-6812-4446-BC73-E1BD9FE9C9FCQ37247954-6DAB17E1-4EC7-42E2-9B85-24B026ED0BF9Q37287170-F270FA20-A84C-4CF9-95D3-CBFBFC1CA919Q38417709-B53A03C0-9956-4853-BE65-766AD4D6BB46Q39710346-78D49CB6-AC55-4EED-96EE-7CA21EDE49AEQ40810927-90A16B99-B412-4D64-B278-50ABEA669349Q40834747-CA60B362-4131-4507-89DC-850AD5553601Q40874415-6FADD57A-41CF-43EF-B340-351FC147316BQ41020855-4AB5141A-ED66-4844-80DC-6DD3AB4B9723Q41455939-03C45BD5-62BC-4948-A945-4F056BD9E3B5Q44856072-1A21778E-BE72-4135-8EF8-47770B48E140Q45862530-FF7B3CFE-5D5E-43E6-8B0B-1B4684BA32D0Q45862807-ECED3C4E-620C-4A7E-9462-4A8E78C2779BQ45868793-03C270A1-8B5B-4B85-BFE4-CF9A60B36068Q58286987-4D629517-10E0-4C40-8680-937EC3FFF14C
P2860
Experimental and clinical studies of cytokine gene-modified tumor cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Experimental and clinical studies of cytokine gene-modified tumor cells.
@en
type
label
Experimental and clinical studies of cytokine gene-modified tumor cells.
@en
prefLabel
Experimental and clinical studies of cytokine gene-modified tumor cells.
@en
P356
P1433
P1476
Experimental and clinical studies of cytokine gene-modified tumor cells.
@en
P2093
P304
P356
10.1089/HUM.1994.5.2-153
P577
1994-02-01T00:00:00Z